Characterization and Significance of Sulfonylurea Receptors

This study describes and characterizes a putative sulfonylurea receptor. The radioligand used was [3H]glipizide (9 Ci/mmol). The β-cell plasma membranes were derived from a transplantable rat insulinoma generated by subcutaneous injection of RINm5F cells and purified by ultracentrifugation on a 15–55% sucrose gradient. Specific binding of [3H]glipizide to purified β-cell plasma membranes was determined to be maximal at temperatures of 4–23°C, pH 7.3, and an incubation of 2 h. Scatchard analysis indicated a single binding site with Kd = 7 nM and sulfonylurea binding of 0.93 pmol/mg membrane protein. Displacement of [3H]glipizide from the purified β-cell plasma membranes by various sulfonylureas and their analogues correlated well with their known hypoglycemic and insulinreleasing activities. Various agents, including nutrients, agents affecting Ca2+ flux, gastrointestinal hormones, and pancreatic hormones, had no effect on [3H]glipizide binding to the β-cell plasma membranes. Putative sulfonylurea receptors on β-cell and brain cell plasma membranes have been reported by several groups of investigators. Sulfonylurea binding to the β-cell is hypothesized to close an ATP-sensitive K+ channel, which leads to depolarization of the membrane and activation of a voltage-dependent Ca2+ channel.

[1]  C. Wollheim,et al.  Specific receptors for sulfonylureas in brain and in a beta-cell tumor of the rat. , 1982, Biochemical pharmacology.

[2]  S. Hamilton,et al.  Characterization of the sulfonylurea receptor on beta cell membranes. , 1988, The Journal of biological chemistry.

[3]  W. Malaisse,et al.  Modalities of Gliclazide-induced Ca2+ Influx into the Pancreatic B-Cell , 1982, Diabetes.

[4]  A. E. Boyd Sulfonylurea Receptors, Ion Channels, and Fruit Flies , 1988, Diabetes.

[5]  A. N. Wick,et al.  The action of a sulfonylurea hypoglycemic agent (orinase) in extrahepatic tissues. , 1956, Metabolism: clinical and experimental.

[6]  M. Lazdunski,et al.  The receptor for antidiabetic sulfonylureas controls the activity of the ATP-modulated K+ channel in insulin-secreting cells. , 1987, The Journal of biological chemistry.

[7]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[8]  J. Sehlin,et al.  The pancreatic -cell recognition of insulin secretagogues. II. Site of action of tolbutamide. , 1971, Biochemical and biophysical research communications.

[9]  N. Lazarus,et al.  Insulin release from the perfused rat pancreas. Mode of action of tolbutamide. , 1974, The Biochemical journal.

[10]  K. Geisen,et al.  Inhibition of 3H-glibenclamide binding to sulfonylurea receptors by oral antidiabetics. , 1985, Arzneimittel-Forschung.

[11]  M. Lazdunski,et al.  Characterization, purification, and affinity labeling of the brain [3H]glibenclamide-binding protein, a putative neuronal ATP-regulated K+ channel. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J. Sehlin,et al.  Glibenclamide is exceptional among hypoglycaemic sulphonylureas in accumulating progressively in beta-cell-rich pancreatic islets. , 1984, Acta endocrinologica.